GS
FBT icon

GTS Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

GTS Securities’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,473
Closed -$761K – 1343
2025
Q1 		$761K Buy
4,473
+2,737
+158% +$475K 0.03% 499
2024
Q4 		$288K Buy
+1,736
New +$297K 0.01% 905
2024
Q1 		– Sell
-39,924
Closed -$6.31M – 4025
2023
Q4 		$6.31M Buy
39,924
+2,452
+7% +$352K 0.01% 854
2023
Q3 		$5.48M Buy
37,472
+2,017
+6% +$307K 0.01% 885
2023
Q2 		$5.41M Buy
+35,455
New +$5.53M 0.17% 120

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GTS Securities's FBT Position: Q2 2025 in Review

GTS Securities sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2025, closing a stake of 4,473 shares — an estimated $761K sold.

GTS Securities first reported a position in FBT in Q2 2023 and held it in 5 quarters. The position peaked at $6.31M in Q4 2023. 250 funds tracked by Wall St. Rank hold FBT as of Q2 2025.

  • GTS Securities reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2025 after selling out during the quarter.
  • GTS Securities sold 4,473 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2025, an estimated $761K.
  • GTS Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2023 and held it in 5 quarters.
  • GTS Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $6.31M in Q4 2023.
  • 250 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.